Preview Newsletter
Verdict Afternoon Media Report 10/28/16
-
Jury awards more than $70M to woman in J&J baby powder cancer lawsuit
Oct 28, 2016 | USA Today
By Roger Yu
A California woman has been awarded more than $70 million after she claimed in a lawsuit that Johnson & Johnson’s baby powder caused her cancer. In a trial that began Sept. 26, Deborah Giannecchini of Modesto, Calif. alleged that her ovarian cancer, diagnosed in in 2012, was a result of her years of use of the product. -
Jury Awards $70 Million to Woman Who Says Baby Power Gave Her Cancer
Oct 28, 2016 | EcoWatch
By Lorraine Chow
A St. Louis jury has awarded $70 million in damages to a California woman who claims she developed ovarian cancer after using Johnson & Johnson's trademark baby powder for decades. The jury also held talc supplier and co-defendant Imerys liable for damages as well. -
Woman wins £58million after claiming Johnson & Johnson baby powder gave her cancer
Oct 28, 2016 | Cosmopolitan UK
By Katie Jones
A woman has been awarded more than £58million in damages after claiming that using Johnson & Johnson's baby powder caused her cancer. Sky News reports that Deborah Giannecchini of Modesto, California, was diagnosed with ovarian cancer in 2012. She accused the pharmaceutical company of "negligent conduct" in the making and marketing of its talcum powder, which raised concerns over the health impact of the product. -
Johnson & Johnson ordered to pay £58 million in baby powder cancer case
Oct 28, 2016 | Evening Standard
By Saphora Smith
Deborah Giannecchini of Modesto, California, blamed the company for 'negligent conduct' after she was diagnosed with ovarian cancer in 2012. Ms Giannecchini accused Jonson & Johnson of failing to make clear the risks of using their product Her lawyer Jim Onder said: “We are pleased the jury did the right thing -
Woman awarded $70 million after claiming baby powder caused her cancer
Oct 28, 2016 | The Cable Lifestyle
By Saminu Machunga
A California woman has been awarded $70 million in damages after claiming that Johnson & Johnson’s baby powder caused her ovarian cancer. Deborah Giannecchini, who has been diagnosed with Stage 4 ovarian cancer, was on Thursday awarded the said sum by a jury in St. Louis. -
Cancer patient who contracted disease after using Johnson & Johnson talcum powder wins $70million payout from the company
Oct 28, 2016 | Angle News
A jury has awarded a woman $70 million in damages against Johnson & Johnson after the woman claimed talcum powder caused her ovarian cancer. Deborah Giannecchini of Modesto, California was diagnosed with the disease in 2012 and accused the company of ‘negligent conduct’ in making and and marketing the baby powder. -
'TALC CANCER RISK' Johnson & Johnson baby powder cancer fears lead to woman being awarded £58m
Oct 28, 2016 | The Sun
By Tom Michael
She sued global brand Johnson & Johnson after accusing the company of “negligent conduct” in their marketing of its baby power. And she was today awarded the mammoth sum by a court in St Louis in the US state of Missouri. Giannecchini’s lawyer Jim Onder said: “We are pleased the jury did the right thing. -
Woman wins £58m payout after lawsuit claiming Johnson's baby powder gave her cancer
Oct 28, 2016 | The Mirror
By Chris Kitching
A US woman has been awarded more than $70m (£58m) by a jury after she claimed Johnson & Johnson's baby powder caused her ovarian cancer. Deborah Giannecchini, 62, used the product for over four decades and accused the multinational of "negligent conduct" in making and marketing the powder. -
Woman wins £58m after Johnson's baby powder 'gave her cancer'
Oct 28, 2016 | ITV
A woman has been awarded more than $70 million (£58 million) for alleging that years of using Johnson & Johnson's baby powder caused her cancer. The case is the latest lawsuit involving talcum powder's link with cancer, as concerns increase about the ramifications on health that extended talc use could have. -
California woman awarded $97.45 million over claims baby talc gave her ovarian cancer
Oct 28, 2016 | Straits Times
A woman from California has been awarded more than US$70 million (S$97.45 million) after a court found that she got ovarian cancer from using Johnson & Johnson's baby talc. -
Michaela
Oct 28, 2016 | HLN
View clip here: http://beta.criticalmention.com/app/#clip/view/24734226?token=6d134546-6326-4d8e-8002-25b506143e89 (1:47) -
Varney & Company
Oct 28, 2016 | Fox Business News
View clip here: http://beta.criticalmention.com/app/#clip/view/24733198?token=07a9bbb8-a2b9-45ad-b125-c1765b68177e (1:35) -
Morning Express with Robin Meade
Oct 28, 2016 | CNN
View clip here: http://beta.criticalmention.com/app/#clip/view/24733076?token=07a9bbb8-a2b9-45ad-b125-c1765b68177e (1:25) -
Good Morning America Video Clip
Oct 28, 2016 | ABC News
View clip here: http://app.criticalmention.com/app/#clip/view/24732855?token=87e9ad0a-166f-4a69-884c-a6991d24780a (0:23)
Traditional US Coverage
Traditional OUS Coverage
National Broadcast
-
Jury awards more than $70M to woman in J&J baby powder cancer lawsuit
Oct 28, 2016 | USA Today
By Roger Yu
A California woman has been awarded more than $70 million after she claimed in a lawsuit that Johnson & Johnson’s baby powder caused her cancer.
In a trial that began Sept. 26, Deborah Giannecchini of Modesto, Calif. alleged that her ovarian cancer, diagnosed in in 2012, was a result of her years of use of the product.
“We are pleased the jury did the right thing. They once again reaffirmed the need for Johnson & Johnson to warn the public of the ovarian cancer risk associated with its product,” Jim Onder, an attorney for the plaintiff, told The Associated Press.
Johnson & Johnson maintains it’s baby powder is perfectly safe. “We deeply sympathize with the women and families impacted by ovarian cancer,” Carol Goodrich, a spokeswoman with Johnson & Johnson, said in a statement. “We will appeal today’s verdict because we are guided by the science, which supports the safety of Johnson’s Baby Powder.”
Some studies suggest a link between talcum powder and ovarian cancer, but scientists say it's not clear yet whether products containing talc can cause the disease.
"Studies of personal use of talcum powder have had mixed results, although there is some suggestion of a possible increase in ovarian cancer risk," the American Cancer Society says on its website. "There is very little evidence at this time that any other forms of cancer are linked with consumer use of talcum powder."
Earlier this year, two other lawsuits in St. Louis ended in jury verdicts worth a combined $127 million. But two others in New Jersey were thrown out by a judge who said there wasn’t reliable evidence that talc leads to ovarian cancer, an often fatal but relatively rare form of cancer. Ovarian cancer accounts for about 22,000 of the 1.7 million new cases of cancer expected to be diagnosed in the U.S. this year.
About 2,000 women have filed similar suits, and lawyers are reviewing thousands of other potential cases, most generated by ads touting the two big verdicts out of St. Louis — a $72 million award in February to relatives of an Alabama woman who died of ovarian cancer, and a $55 million award in May to a South Dakota survivor of the disease.
Talcum powder is made from talc, which absorbs moisture well and helps cut down on friction. That makes it useful for keeping skin dry and preventing rashes. The powder was used for many years when diapering babies, but health concerns led doctors to recommend against its use. Talc is still widely used in other cosmetics.
-
Jury Awards $70 Million to Woman Who Says Baby Power Gave Her Cancer
Oct 28, 2016 | EcoWatch
By Lorraine Chow
A St. Louis jury has awarded $70 million in damages to a California woman who claims she developed ovarian cancer after using Johnson & Johnson's trademark baby powder for decades. The jury also held talc supplier and co-defendant Imerys liable for damages as well.
Thursday's verdict is the third consecutive loss for the company over repeated claims that extended use of talcum powder can cause this relatively rare but lethal form of cancer. Two previous St. Louis juries awarded verdicts to plaintiffs Jacqueline Fox and Gloria Ristesund of $72 million and $55 million after concluding that talc exposure causes ovarian cancer.
The latest case involves Deborah Giannecchini of Modesto, California, who was 59 when she was diagnosed with Stage IV ovarian cancer four years ago, according to Montgomery, Alabama-based law firm Beasley Allen.
Giannecchini had used Johnson & Johnson's Baby Powder for feminine hygiene for more than 40 years. She has gone through multiple surgeries, chemotherapy regimens and even had her spleen, colon, uterus and ovaries removed. Her lawyers said that she has an 80 percent chance of dying in the next two years, according to Bloomberg. The lawsuit accused the company of "negligent conduct" in making and marketing its baby powder.
"Yet another jury has heard the evidence outlining a link between Johnson & Johnson's talcum powder products and ovarian cancer, and has decided that there is a clear connection," Beasley Allen lawyer Ted Meadows, who helped lead the litigation, said in a statement.
"When is enough going to be enough? Despite repeated verdicts that hold the company accountable, Johnson & Johnson has refused to remove its talcum powder products from shelves, has refused to warn consumers about the risk, and continues to deny its responsibility. It's time for this company to come clean and put consumer health ahead of profits."
The jurors came up with their verdict after three hours of deliberation. Juror Billie Ray, 76, of St. Louis, told Bloomberg after the trial that Johnson & Johnson should have provided a warning label on the product to let consumers decide whether to use the product.
"It seemed like Johnson & Johnson didn't pay attention," she said. "It seemed like they didn't care."
Giannecchini was also pleased with the outcome. "I've waited for a long time for this," she told Bloomberg. "I've wanted this so badly."
About 2,000 women have filed suits against Johnson & Johnson over talcum powder's link to ovarian cancer.
Beasley Allen stated in its press release that "the disease strikes about one in 70 women, though studies show that women who use talc-containing products on their genitals as a daily hygiene habit have a 30 to 60 percent increased risk of developing ovarian cancer."
"An expert at trial testified that in the last 34 years, since the time of the first epidemiological study in 1982, approximately 127,500 women have died as a result of ovarian cancer that could be attributed to talcum powder use on the genitals, and an estimated 1,500 women will die within the next year as a result of talc use," the firm added.
However, the American Cancer Society states that many scientific findings have been mixed, with some studies reporting a slightly increased risk and some reporting no increase.
Johnson & Johnson maintains that their flagship product is perfectly safe and all three cases are being appealed.
Spokeswoman Carol Goodrich released the following statement:
"We deeply sympathize with the women and families impacted by ovarian cancer. We will appeal today's verdict because we are guided by the science, which supports the safety of Johnson's Baby Powder. In fact, two cases pending in New Jersey were dismissed in September 2016 by a state court judge who ruled that plaintiffs' scientific experts could not adequately support their theories that talcum powder causes ovarian cancer, a decision that highlights the lack of credible scientific evidence behind plaintiffs' allegations."
Imerys spokesman Dan Rene told Bloomberg that the company is "disappointed'' with the verdict. The company had been cleared in the two previous St. Louis trials.
"This verdict serves to undermine efforts by the scientific community to determine the true causes of ovarian cancer,'' Rene added. "The theories relied upon by plaintiffs' experts lacked scientific foundation.''
-
Woman wins £58million after claiming Johnson & Johnson baby powder gave her cancer
Oct 28, 2016 | Cosmopolitan UK
By Katie Jones
A woman has been awarded more than £58million in damages after claiming that using Johnson & Johnson's baby powder caused her cancer.
Sky News reports that Deborah Giannecchini of Modesto, California, was diagnosed with ovarian cancer in 2012. She accused the pharmaceutical company of "negligent conduct" in the making and marketing of its talcum powder, which raised concerns over the health impact of the product.
"We are pleased the jury did the right thing," Jim Onder, the woman's lawyer, said in a statement following the St. Louis jury's ruling. "They once again reaffirmed the need for Johnson & Johnson to warn the public of the ovarian cancer risk associated with its product."
However, according to CBS News, a Johnson and Johnson lawyer stressed there is no scientific evidence linking talcum powder with cancer, and he asked the jury to not listen to "that dark side of your heart that thinks everybody's a conspirator."
A spokesperson for the brand echoed this view in her statement.
"We deeply sympathise with the women and families impacted by ovarian cancer," Carol Goodrich said. "We will appeal today's verdict because we are guided by the science, which supports the safety of Johnson's Baby Powder."
This is the latest trial the multinational has lost in a row over the health risks associated with extended use of its popular product.
Earlier this year, a jury in Missouri ordered Johnson & Johnson to pay almost £60million in damages to the family of a woman who said her ovarian cancer was linked to their talcum powder. This was the first verdict that ordered the company to pay out, but according to Reuters, there have been hundreds of similar lawsuits about the supposed connection.
Not every claimant has been successful, though. The Independent reports two other cases in New Jersey were thrown out by a judge who said there wasn't reliable evidence that talcum powder causes ovarian cancer.
Researchers and major health organisations say talc, which is a mineral that is widely used in cosmetics to absorb moisture, is harmless and Johnson & Johnson insists it's perfectly safe.
The International Agency for Research on Cancer classifies use of talc for feminine hygiene as "possibly carcinogenic to humans," while the National Toxicology Program has not fully reviewed it as a possible carcinogen.
The court ruling comes after a dispute over possible carcinogenic ingredients found in Johnson & Johnson's products in 2012. The company pledged to remove 1,4-dioxane and formaldehyde from its range by 2015.
-
Johnson & Johnson ordered to pay £58 million in baby powder cancer case
Oct 28, 2016 | Evening Standard
By Saphora Smith
Deborah Giannecchini of Modesto, California, blamed the company for 'negligent conduct' after she was diagnosed with ovarian cancer in 2012.
Ms Giannecchini accused Jonson & Johnson of failing to make clear the risks of using their product
Her lawyer Jim Onder said: “We are pleased the jury did the right thing
“They once again reaffirmed the need for Johnson & Johnson to warn the public of the ovarian cancer risk associated with its product.”
The case is one of many against the cosmetic company after some research found that using talc on female genitals can increase women’s risk of developing cancer by 40 per cent.
Johnson & Johnson deny the claims.
In a statement following the ruling the brand said: "We will appeal today's verdict because we are guided by the science, which supports the safety of Johnson's Baby Powder."
The International Agency for Research on Cancer classifies genital use of talc as “possibly carcinogenic.”
-
Woman awarded $70 million after claiming baby powder caused her cancer
Oct 28, 2016 | The Cable Lifestyle
By Saminu Machunga
A California woman has been awarded $70 million in damages after claiming that Johnson & Johnson’s baby powder caused her ovarian cancer.
Deborah Giannecchini, who has been diagnosed with Stage 4 ovarian cancer, was on Thursday awarded the said sum by a jury in St. Louis.
The suit accused Johnson & Johnson of “negligent conduct” by making and marketing its baby powder – which had used for several years.
“We are pleased the jury did the right thing. They once again reaffirmed the need for Johnson & Johnson to warn the public of the ovarian cancer risk associated with its product,” Jim Onder, an attorney for the plaintiff, told The Associated Press.
“We deeply sympathize with the women and families impacted by ovarian cancer,” Carol Goodrich, a spokeswoman with Johnson & Johnson, said in a statement.
“We will appeal today’s verdict because we are guided by the science, which supports the safety of Johnson’s Baby Powder.”
According to ABC, earlier this year, two other lawsuits in St. Louis ended in jury verdicts worth a combined $127 million.
About 2,000 women have filed similar suits, and lawyers are reviewing thousands of other potential cases.
According to a press release from the law firm representing her, the award breakdown is as follows:
$575,000 in economic damages $2,000,000 Million in non-economic damages $65 Million in punitive damages against Johnson & Johnson $2.5 Million in punitive damages against Imerys
-
Oct 28, 2016 | Angle News
A jury has awarded a woman $70 million in damages against Johnson & Johnson after the woman claimed talcum powder caused her ovarian cancer.
Deborah Giannecchini of Modesto, California was diagnosed with the disease in 2012 and accused the company of ‘negligent conduct’ in making and and marketing the baby powder.
The lawsuit claimed Mrs Giannecchini contracted the disease after using baby powder in an intimate area.
Deborah Giannecchini of Modesto, California claimed using Johnson & Johnson’s baby powder in an intimate fashion over the course of many years led to her developing ovarian cancer
Jim Onder, Mrs Giannecchini’s lawyer said: ‘We are pleased the jury did the right thing. They once again reaffirmed the need for Johnson & Johnson to warn the public of the ovarian cancer risk associated with its product.’
Yet, the company has rejected there is any risk to using their product – even in intimate areas and will appeal the massive award.
Carol Goodrich, spokeswoman for the company said: ‘We deeply sympathize with the women and families impacted by ovarian cancer. We will appeal today’s verdict because we are guided by the science, which supports the safety of Johnson’s Baby Powder.’
Earlier this year, two other lawsuits in St. Louis ended in jury verdicts worth a combined $127 million. But two others in New Jersey were thrown out by a judge who said there wasn’t reliable evidence that talc leads to ovarian cancer, an often fatal but relatively rare form of cancer.
Ovarian cancer accounts for about 22,000 of the 1.7 million new cases of cancer expected to be diagnosed in the U.S. this year.
About 2,000 women have filed similar suits, and lawyers are reviewing thousands of other potential cases, most generated by ads touting the two big verdicts out of St. Louis — a $72 million award in February to relatives of an Alabama woman who died of ovarian cancer, and a $55 million award in May to a South Dakota survivor of the disease.
Johnson & Johnson deny that using their product increases the risk of developing ovarian cancer, pictured here, and plan to appeal the $70 million award to Mrs Giannecchini
Much research has found no link or a weak one between ovarian cancer and using baby powder for feminine hygiene, and most major health groups have declared talc harmless. Johnson & Johnson, whose baby powder dominates the market, maintains it’s perfectly safe.
But Onder of the Onder Law Firm in suburban St. Louis, which represented plaintiffs in all three St. Louis cases, cited other research that began connecting talcum powder to ovarian cancer in the 1970s.
He said case studies have indicated that women who regularly use talc on their genital area face up to a 40 percent higher risk of developing ovarian cancer.
Onder has accused Johnson & Johnson of marketing toward overweight women, blacks and Hispanics — the very same women most at-risk for ovarian cancer, he said.
Factors known to increase a women’s risk of ovarian cancer include age, obesity, use of estrogen therapy after menopause, not having any children, certain genetic mutations and personal or family history of breast or ovarian cancer.
The International Agency for Research on Cancer classifies genital use of talc as ‘possibly carcinogenic’. The National Toxicology Program, made up of parts of several different government agencies, has not fully reviewed talc.
Talc is a mineral that is mined from deposits around the world, including the U.S. The softest of minerals, it’s crushed into a white powder. It’s been widely used in cosmetics and other personal care products to absorb moisture since at least 1894, when Johnson & Johnson’s Baby Powder was launched. But it’s mainly used in a variety of other products, including paint and plastics.
The two St. Louis verdicts were the first talcum powder cases in which money was awarded. A federal jury in 2013 sided with another South Dakota woman, but it ordered no damages, a spokeswoman for Onder’s firm said.
Johnson & Johnson has been targeted before by health and consumer groups over ingredients in its products, including Johnson’s No More Tears baby shampoo. The company agreed in 2012 to eliminate 1,4-dioxane and formaldehyde, both considered probable carcinogens, from all products by 2015.
-
'TALC CANCER RISK' Johnson & Johnson baby powder cancer fears lead to woman being awarded £58m
Oct 28, 2016 | The Sun
By Tom Michael
She sued global brand Johnson & Johnson after accusing the company of “negligent conduct” in their marketing of its baby power.
And she was today awarded the mammoth sum by a court in St Louis in the US state of Missouri.
Giannecchini’s lawyer Jim Onder said: “We are pleased the jury did the right thing.
“They once again reaffirmed the need for Johnson & Johnson to warn the public of the ovarian cancer risk associated with its product.”
The case is the latest surrounding the alleged links between baby power and the disease.
The International Agency for Research on Cancer classifies genital use of talc as “possibly carcinogenic”.
Some studies have found that women who regularly use talc on their genital area face up to a 40 percent higher risk of developing ovarian cancer.
Other research however, has shown either no link or a weak link between cancer the product.
But today’s decision will come as a blow to the company, which is arguably more famous for its baby powder than any of its other products.
“We deeply sympathise with the women and families impacted by ovarian cancer,” Carol Goodrich, a spokeswoman with Johnson & Johnson, said in a statement.
“We will appeal today’s verdict because we are guided by the science, which supports the safety of Johnson’s Baby Powder.”
Earlier this year, two other lawsuits in St. Louis ended in jury verdicts worth a combined £104million.
But two others in New Jersey were thrown out by a judge who said there wasn’t reliable evidence that talc leads to ovarian cancer, an often fatal but relatively rare form of the disease.
-
Woman wins £58m payout after lawsuit claiming Johnson's baby powder gave her cancer
Oct 28, 2016 | The Mirror
By Chris Kitching
A US woman has been awarded more than $70m (£58m) by a jury after she claimed Johnson & Johnson's baby powder caused her ovarian cancer .
Deborah Giannecchini, 62, used the product for over four decades and accused the multinational of "negligent conduct" in making and marketing the powder.
The jury delivered its verdict in a St Louis , Missouri, courtroom after around three hours of deliberation, and Johnson & Johnson has said it will appeal.
The New Jersey-based company insists its talcum products are safe and there is no scientific evidence that they cause health problems.
Ms Giannecchini, from Modesto, California, was diagnosed with ovarian cancer in 2012.
After undergoing surgery, radiation and chemotherapy her chance of survival over the next two years is just 20 per cent.
Her lawyer told the trial she has had her ovaries, colon and spleen removed after using talc products, and accused Johnson & Johnson of being aware of the risk and failing to warn users.
A number of recent civil cases against Johnson & Johnson have raised concerns about health problems associated with long-term use of talcum powder.
This is the third lawsuit Johnson & Johnson has lost in the US this year to users of its baby and body powders - with awards totalling nearly $200m (£165m).
Juries awarded $72m (£59m) to an Arkansas woman who died of ovarian cancer and $55m (£45m) to a South Dakota woman who survived.
Both of those cases are being appealed as well.
Each case was won by personal injury lawyer Jim Onder, who told CBS News following Thursday's verdict: "The families that we've represented are not in it for the money.
"They're in it to save the lives of others...and to force Johnson & Johnson to do the right thing."
He added: "The fact that they say that the science does not support it, is nothing short of an outright lie."
The jury ordered Johnson & Johnson to pay $65m (£54m) and 90 per cent of Ms Giannecchini's medical costs, while co-defendant and supplier Imerys Talc America must pay $2.5m (£2m).
Talc is the softest of minerals that is crushed into a white powder and widely used in cosmetics and personal hygiene products to absorb moisture.
It is used in a variety of other products including paint and plastics.
-
Woman wins £58m after Johnson's baby powder 'gave her cancer'
Oct 28, 2016 | ITV
A woman has been awarded more than $70 million (£58 million) for alleging that years of using Johnson & Johnson's baby powder caused her cancer.
The case is the latest lawsuit involving talcum powder's link with cancer, as concerns increase about the ramifications on health that extended talc use could have.
Johnson & Johnson said they will appeal the decision and insist that science proves their product is safe.
Californian Deborah Giannecchini was diagnosed with ovarian cancer in 2012. The suit accused Johnson & Johnson of "negligent conduct" in making and marketing its baby powder.
Earlier this year, two lawsuits in the United States ended in jury verdicts worth a combined $127 million (£105 million).
But two other lawsuits were thrown out by a New Jersey judge who said there wasn't reliable evidence that talc leads to ovarian cancer.
A statement from Carol Goodrich, spokesperson for Johnson & Johnson said: "We deeply sympathize with the women and families impacted by ovarian cancer.
"We will appeal today's verdict because we are guided by the science, which supports the safety of Johnson's Baby Powder.
"In fact, two cases pending in New Jersey were dismissed in September 2016 by a state court judge who ruled that plaintiffs' scientific experts could not adequately support their theories that talcum powder causes ovarian cancer, a decision that highlights the lack of credible scientific evidence behind plaintiffs' allegations."
-
California woman awarded $97.45 million over claims baby talc gave her ovarian cancer
Oct 28, 2016 | Straits Times
A woman from California has been awarded more than US$70 million (S$97.45 million) after a court found that she got ovarian cancer from using Johnson & Johnson's baby talc.
Ms Deborah Giannecchini of Modesto had accused the firm of "negligent conduct" in making and marketing the product, reported Sky News.
The company insists the product is safe, with some research finding no link or a weak one between ovarian cancer and baby powder. But other research has found that women who regularly use talc on their genital area face a 40 per cent higher risk of developing ovarian cancer.
The woman's lawyer Jim Onder said: "We are pleased the jury did the right thing. They once again reaffirmed the need for Johnson & Johnson to warn the public of the ovarian cancer risk associated with its product."
But Johnson & Johnson said in a statement: "We will appeal today's verdict because we are guided by the science, which supports the safety of Johnson's Baby Powder."
Two similar lawsuits in St Louis ended in verdicts worth a combined US$127 million against the company, but two others in New Jersey were thrown out by a judge.
About 2,000 women have filed similar lawsuits and lawyers are reviewing thousands of cases, reported Sky News.
-
Oct 28, 2016 | HLN
View clip here: http://beta.criticalmention.com/app/#clip/view/24734226?token=6d134546-6326-4d8e-8002-25b506143e89
(1:47)
Rough transcript: Johnson & Johnson. they have just lost another multimillion-dollar lawsuit connected to a product you very well may have in your home. a jury has sided with a woman who said J&J’s baby powder is linked to her ovarian cancer. Money talk’s correspondent maribel is here. maybe you can walk us through what happened here. >> the lawsuit involved a california woman who used as you mentioned J&J’s baby powder for four decades through her 20s 30s 40s and 50s. she used the products and was diagnosed with the cancer in her late 50s, so she's suing the company claiming there was this link between talcom powder and ovarian cancer. And it took a jury in st louis three hours to side with her. she's been awarded more than $70 million. the woman's lawyer says you know what johnson & johnson was aware of 30 years of studies showing an increased risk of ovarian cancer and the use of talc. now johnson & johnson says science supports the safety of its baby powder, but after the verdict one juror said the company should have added a warning label to the product. The juror went on to say mic that it was like Johnson & Johnson didn’t care. >> wow and this is not the end of the road, there are other lawyer suits, right? they're facing more civil action. >> plenty more. and actually this lawsuit was the third one johnson & johnson lost this year. two previous suits tied to its products and ovarian caner ended in jury verdicts worth a combined $127 million. johnson & johnson is appealing those according to bloomberg and right now the company is accused in about 1700 lawsuits in both federal and state court on this very issue Mic. >> that’s going to have impact on their bottom line to be sure.
-
Oct 28, 2016 | Fox Business News
View clip here: http://beta.criticalmention.com/app/#clip/view/24733198?token=07a9bbb8-a2b9-45ad-b125-c1765b68177e
(1:35)
Rough transcript: i can't believe this, a jury in st. louis awards a woman $70 million dollars. she alleges in her lawsuit that years of using Johnson & Johnson baby powder, talcum powder, caused her ovarian cancer. she's back, katie phang. Still with us. Katie, you know. what? Why? 70 million dollars for talcum powder use? what's going on here? >> okay, so i thought texas everything was bigger in texas. i guess everything’s bigger in st. louis, including runaway jury verdicts. $72 million. earlier this year in one jury trial, 50 million. a few months later all in st. louis. there's a common denominator here and it's the fact that st. louis juries do not like johnson & Johnson and they think that if you use talcum powder near your genitals and you’re a woman and you’re a minority especially, because they’re claiming that minority women are being targeted by Johnson & Johnson and their negligent marketing and manufacturing, that you have contracted or you have been diagnosed with ovarian cancer. these numbers are outrageous, this is the reason why they get tort reform, but you know look, there's no causal link. according to johnson & johnson, they say the studies, they say the studies are biased. that people have to rely upon the memories of how they use the talcum powder and how often. So absence of scientific and legal link, it’s absurd.
-
Morning Express with Robin Meade
Oct 28, 2016 | CNN
View clip here: http://beta.criticalmention.com/app/#clip/view/24733076?token=07a9bbb8-a2b9-45ad-b125-c1765b68177e
(1:25)
Rough transcript: here is a product that you might be using today. and a third jury is now apparently conveying that it believes that baby powder might be the cause of one woman's ovarian cancer. so money expert jen fills you in. this is a case out of st. louis and it’s about johnson & johnson baby powder and the woman is going to get $70 million dollars. Wow good morning. >> that's the verdict. yes. $70 million for this woman. it's again it’s the third -- all three have been major tens of millions of verdicts going against johnson & johnson. Now johnson & johnson said they'll appeal, they’re appealing all three. they said, look, the science is and most major health groups agree with them, that there's no proven link but, again, it's the third jury that disagreed with them. so you have to think about whether or not johnson & johnson what they're thinking about their future legal strategy. since they are facing 1700 more lawsuits like this. Here’s what you should know. the woman's lawyers say that for 30 years there have been many studies and some of them have shown a link and they believe johnson & Johnson should be warning people about this. there are others who argue they should not be using talc instead. Now this is different from the corn starch baby powder. But still we'll continue to watch that one. Many more trials to come.
-
Good Morning America Video Clip
Oct 28, 2016 | ABC News
View clip here: http://app.criticalmention.com/app/#clip/view/24732855?token=87e9ad0a-166f-4a69-884c-a6991d24780a
(0:23)
Rough Transcript: A California woman has been awarded $70 million in a lawsuit stemming from the use of baby powder and its alleged link to cancer. she sued johnson & johnson claiming her ovarian cancer was caused by years of using its talcum powder. the company is facing about 1700 lawsuits. it plans to appeal insisting scientific evidence proves its powder safe.
Traditional US Coverage
Traditional OUS Coverage
National Broadcast
Add recipients
Suggested